Acquisition Announced

LEO Pharma acquisition of Replay

US$50m consideration

Announced May 2026

Advisers

Target
Replay
Acquirer
LEO Pharma
Target based in
United States (unverified)
Buyer based in
Denmark
Sector
Biotech
Tags
Biotech, Dermatology, Rare Disease

In the league tables

Similar deals

All biotech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.